EMERGING EVIDENCE THAT MAKES A BIG DIFFERENCE
adherence-hero

Factors associated with adherence to aspirin therapy4-6

Predictors of low-dose aspirin non-compliance

CV: cardiovascular; CAD: coronary artery disease.

References

  1. Singh G, Arora G, Mannalithara A, Mithal A, Sehgal A, Triadafilopoulos G. Alarmingly poor adherence to low-dose aspirin: a large population-based study. Eur Heart J. 2013;34(suppl 1):P2522.
  2. Soomro H, Aleem S, Hussain M, et al. Frequency and Predictors of Non-Compliance to Aspirin Therapy in Post Myocardial Infarction Patients. Glob J Health Sci. 2016;9(1):217-223.
  3. Biondi-Zoccai G, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at riskfor coronary artery disease. European Heart Journal. 2006;27(22):2667-2674.
  4. Carney R, Freedland K, Eisen S, Rich M, Jaffe A. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology. 1995;14(1):88-90.
  5. Newby L, Allen LaPointe N, Chen A et al. Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease. Circulation. 2006;113(2):203-212.
  6. Glynn R, Buring J, Manson J, LaMotte F, Hennekens C. Adherence to Aspirin in the Prevention of Myocardial Infarction. Archives of Internal Medicine. 1994;154(23):2649-57.